Literature DB >> 14499176

Is there a psychoneuroimmunological pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia.

Olivier Guilbaud1, Maurice Corcos, Linnea Hjalmarsson, Gwenolé Loas, Philippe Jeammet.   

Abstract

The term "alexithymia" was coined by Sifneos. It is characterised by a lack of words to express emotion (a: absence of; lexi: words; thymia: emotions, affects). Its characteristics were suggested to occur more frequently in individuals with so-called "psychosomatic disorders", but this is still a matter of controversy. Here we review the psychosomatic network of alexithymia, i.e. the immune and physiological correlates of alexithymia. Some studies suggest that inaccuracy in recognising emotional states, or the way of coping with negative emotions, may influence immune function. Alexithymia is associated with higher tonic baseline levels of sympathetic activity and lower sympathetic reactivity during acute stress. Few studies have reported a diminished immune-mediated cellular response in alexithymics with oversecretion of glucocorticoids. We hypothesise that alexithymic subjects may suffer from unnoticed chronic stress with physiological and endocrine and immune consequences. Alexithymia may skew the Th-1/Th-2 balance toward Th-2 dominant immunity and lower cell-mediated (Th-1) immune response and may increase an individual's risk for stress-related disorder.

Entities:  

Mesh:

Year:  2003        PMID: 14499176     DOI: 10.1016/s0753-3322(03)00085-4

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

Review 1.  The assessment of alexithymia in medical settings: implications for understanding and treating health problems.

Authors:  Mark A Lumley; Lynn C Neely; Amanda J Burger
Journal:  J Pers Assess       Date:  2007-12

Review 2.  Development of alexithymic personality features.

Authors:  Max Karukivi; Simo Saarijärvi
Journal:  World J Psychiatry       Date:  2014-12-22

3.  Alexithymia in Patients with Ménière Disease: A Possible Role on Anxiety and Depression.

Authors:  Roberto Teggi; Claudia Yvonne Finocchiaro; Claudio Ruggieri; Omar Gatti; Federica Rosolen; Mario Bussi; Lucio Sarno
Journal:  Audiol Res       Date:  2021-02-23

4.  Psychological Distress Mediates the Effect of Alexithymia on 2-Year Change in HIV Viral Load.

Authors:  Roger C McIntosh; Gail Ironson; Michael Antoni; Betty Lai; Mahendra Kumar; Mary Ann Fletcher; Neil Schneiderman
Journal:  Int J Behav Med       Date:  2017-04

5.  Measuring Alexithymia via Trait Approach-I: A Alexithymia Scale Item Selection and Formation of Factor Structure.

Authors:  Arkun Tatar; Gaye Saltukoğlu; Seda Alioğlu; Sümeyye Çimen; Hülya Güven; Çağla Ebru Ay
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

6.  Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Marta Vadacca; Rosa Bruni; Nicolò Terminio; Gianluca Sambataro; Domenico Margiotta; Francesco Maria Serino; Antonella Afeltra
Journal:  Clin Rheumatol       Date:  2014-04-11       Impact factor: 2.980

Review 7.  Psychosocial Mediators of Change and Patient Selection Factors in Oral Immunotherapy Trials.

Authors:  Audrey Dunn Galvin; J O'B Hourihane
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

8.  Personality and the risk of cancer: a 16-year follow-up study of the GAZEL cohort.

Authors:  Cédric Lemogne; Silla M Consoli; Béatrice Geoffroy-Perez; Mireille Coeuret-Pellicer; Hermann Nabi; Maria Melchior; Frédéric Limosin; Marie Zins; Pierre Ducimetière; Marcel Goldberg; Sylvaine Cordier
Journal:  Psychosom Med       Date:  2013-03-19       Impact factor: 4.312

9.  Neurocognitive correlates of alexithymia in asymptomatic individuals with HIV.

Authors:  Yelena Bogdanova; Mirella Díaz-Santos; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2009-12-28       Impact factor: 3.139

10.  Alexithymia and acne vulgaris: a case control study.

Authors:  Didem Sunay; Murat Baykir; Gülfem Ateş; Meral Ekşioğlu
Journal:  Psychiatry Investig       Date:  2011-11-03       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.